This HTML5 document contains 164 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n11	http://dx.doi.org/10.1016/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
p	http://www.wikidata.org/prop/
wikibase	http://wikiba.se/ontology#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q38721154

rdf:type

wikibase:Item

schema:description

scienca artikolo научна статия επιστημονικό άρθρο artigo científico artykuł naukowy 2017年论文 2017年論文 artigo científico บทความทางวิทยาศาสตร์ 2017年論文 wetenschappelijk artikel სამეცნიერო სტატია artículu científicu espublizáu en 2017 2017년 논문 article scientifique artikel ilmiah vitenskapelig artikkel article scientific 2017年論文 articol științific scientific article published on 14 June 2017 artículo científico publicado en 2017 teaduslik artikkel 2017年論文 article científic scientific article published on 14 June 2017 2017年论文 наукова стаття, опублікована в червні 2017 научни чланак artikulong pang-agham научни чланак 2017年の論文 2017年论文 wissenschaftlicher Artikel ১৪ জুন ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ scientific article published on 14 June 2017 bài báo khoa học научная статья 2017年論文 מאמר מדעי 2017年论文 naučni članak tieteellinen artikkeli artigo científico videnskabelig artikel 2017年论文 vetenskaplig artikel articolo scientifico 2017年论文 tudományos cikk bilimsel makale vedecký článok artikull shkencor 2017 nî lūn-bûn مقالة علمية نشرت في 14 يونيو 2017 vitskapeleg artikkel vědecký článek

p:P577

wds:Q38721154-8AF1DDB8-A06A-457A-B4FF-9204174400C2

wdt:P577

2017-06-16T00:00:00Z

p:P407

wds:Q38721154-29323553-4AB0-4E5E-B8BF-F6C20AA5E501

wdt:P407

wd:Q1860

p:P2860

wds:Q38721154-FBBE0339-CEE3-4F9B-9F49-A344F1FDA4B4 wds:Q38721154-CCB87BC0-EF12-4B43-99B3-19899966FF5E wds:Q38721154-D0679F9E-B725-4B37-BE77-2EBB34565EA6 wds:Q38721154-F779B318-F73A-41A4-B168-9EAEE0108D17 wds:Q38721154-96BFC2BD-8468-4A35-B817-0BC6A0FA1961 wds:Q38721154-AB012B50-3CE8-4770-8446-C353DA913035 wds:Q38721154-0452CF36-780D-498E-8845-8F91E1A13E98 wds:Q38721154-BEEE57CA-7CF1-47F3-AAA5-F893E4D11BD1 wds:Q38721154-054D06B0-3E76-4ACD-BA58-60BC07422B33 wds:Q38721154-26C2F177-5A4D-4CD3-BB90-136448B1676C wds:Q38721154-89579AF0-7560-4D13-ADC9-20A78058BAE4 wds:Q38721154-441DDA17-2589-4DA9-9DA0-035C30F0B563 wds:Q38721154-6645C7B0-F880-45FF-B571-BDA732B9E9B3 wds:Q38721154-67165EFE-C9C2-4173-99F7-AEDE732D2BBF wds:Q38721154-6B823DA1-1A3F-4819-AA54-B9C11FFF6223 wds:Q38721154-6CB3124F-8D71-418F-A4C0-F954AE894A4A wds:Q38721154-2BEE17AB-3F92-4466-8083-5DEFAF6B063D wds:Q38721154-31EF77A1-DC3C-49DC-800E-F87B4D905654 wds:Q38721154-35A08D3F-76AA-47D0-800F-2095473DB9A2 wds:Q38721154-367B52E9-14F4-4D3E-960F-71773053CC70

wdt:P2860

wd:Q34637622 wd:Q45391764 wd:Q48285823 wd:Q50860685 wd:Q51988004 wd:Q42658656 wd:Q30196893 wd:Q37291850 wd:Q51030867 wd:Q45364396 wd:Q51032470 wd:Q37135095 wd:Q41355357 wd:Q64125689 wd:Q28239937 wd:Q54678968 wd:Q37530077 wd:Q35944621 wd:Q51035575 wd:Q40707546

p:P2093

wds:Q38721154-6D3CC51C-C853-4C9F-9524-E65FB7C3A049 wds:Q38721154-6B4DDA51-8A51-435E-838D-9C8E9624EA50 wds:Q38721154-5DA6A553-B42B-4946-AAC4-E01217C609DB wds:Q38721154-3C300C68-9C4A-4531-8295-8BCB364B53A7 wds:Q38721154-2F7AA9BD-68B5-42AD-B45A-1FA038536F15 wds:Q38721154-2E75D4D0-A161-4132-A4FF-26A721F31B02 wds:Q38721154-B646D8CA-35AF-4D27-B180-46CEA45468D9 wds:Q38721154-86404521-3E5B-4BB5-8583-7065FCE8AE9B wds:Q38721154-7C547C4B-D58C-417B-8194-2F8C6A199826 wds:Q38721154-84562A5A-A13A-4A2E-8A22-495A16578A3C wds:Q38721154-79379762-00B4-47F1-8C6A-251E7D7798FD wds:Q38721154-FB7B8659-220C-458F-B4BD-18004F61D14F wds:Q38721154-D8322EDD-B03A-46E4-9DA8-27D75F68E192

wdt:P2093

Alessandro Zanetti Luisa Romanò Giorgio Zoppi Antonio d'Alessandro Maria Giuseppina Desole Cécile Eymin Michele Conversano Maria Grazia Panico Massimo Zuliani Stéphane Thomas Giuseppe Ferrera Benoît Soubeyrand Alberto Tomasi

rdfs:label

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

skos:prefLabel

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

schema:name

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

p:P50

wds:Q38721154-F14EF298-4A15-44D8-AE5F-E990D90BBE85

wdt:P50

wd:Q42236017

p:P1476

wds:Q38721154-B7692F8A-D0D2-448A-A34F-CEBE147F930D

wdt:P1476

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy

p:P304

wds:Q38721154-0A5141C4-6945-496C-BDDB-4DB3F37AD7D6

wdt:P304

4034-4040

p:P31

wds:Q38721154-C6773D01-0BAF-4C2A-825C-9B025F53E773

wdt:P31

wd:Q13442814

p:P921

wds:Q38721154-8494C455-F639-4B6C-8353-DAD0D9C91634 wds:Q38721154-75745EA9-A092-4F85-827F-B55865700F0E wds:Q38721154-F11B8611-C47C-4EA3-8717-5FB2C35C1DCB

wdt:P921

wd:Q117749 wd:Q38 wd:Q6934595

p:P698

wds:Q38721154-E907B9E5-42EB-4AED-994B-17B6CB5C1F96

wdtn:P698

n12:28624307

wdt:P698

28624307

p:P1433

wds:Q38721154-427E24C9-53FE-4511-B59A-E99F121EDDE6

wdt:P1433

wd:Q7907941

p:P433

wds:Q38721154-89D9EF48-CD93-4929-AEF3-F4C616B3345D

p:P478

wds:Q38721154-DE8F9B14-D231-442C-8A77-B608CEA284CE

wdt:P433

32

wdt:P478

35

p:P356

wds:Q38721154-BFF95377-51CA-48CA-8833-87DDA90F24FA

wdtn:P356

n11:J.VACCINE.2017.05.047

wdt:P356

10.1016/J.VACCINE.2017.05.047